Who owns PHOENIX BIOTECH ACQUISITION?
- Ticker: CEROW
- CUSIP Number: 71902k113
Tip: Access positions for across all investors
Analyze quarterly positions in Phoenix Biotech Acquisition with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Phoenix Biotech Acquisition stock
Who bought or sold PHOENIX BIOTECH ACQUISITION this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Highbridge Capital Management | 830k | $17k | 0% | Jun 2024 |
|
| Cowen And Company | 687k | $14k | 8% | Jun 2024 |
|
| Periscope Capital | 592k | $40k | -38% | Mar 2024 |
|
| Cantor Fitzgerald, L. P. | 441k | $8.9k | 0% | Jun 2024 |
|
| Atalaya Capital Management | 425k | $8.5M | 0% | Jun 2024 |
|
| MMCAP International Inc. SPC | 375k | $7.5k | 0% | Jun 2024 |
|
| Saba Capital Management | 296k | $5.9k | 0% | Jun 2024 |
|
| Shaolin Capital Management | 268k | $5.4k | 0% | Jun 2024 |
|
| Q Global Advisors | 171k | $3.0k | 0% | Jun 2024 |
|
| Clear Street | 145k | $3.0k | 1% | Jun 2024 |
|
| Context Capital Management | 122k | $2.5k | 0% | Jun 2024 |
|
| Millennium Management | 109k | $2.2k | 0% | Jun 2024 |
|
| Highland Capital Management Fund Advisors | 109k | $2.2k | 0% | Jun 2024 |
|
| Picton Mahoney Asset Management | 75k | $997.500000 | 0% | Jun 2024 |
|
| Westchester Capital Management | 75k | $1.5k | 0% | Jun 2024 |
|
| Kim | 50k | $1.0k | 0% | Jun 2024 |
|
| Tenor Capital Management | 50k | $1.0M | 0% | Jun 2024 |
|
| Yakira Capital Management | 50k | $3.4k | 100% | Mar 2024 |
|
| Wolverine Asset Management | 44k | $880.299600 | -32% | Jun 2024 |
|
| Hrt Financial | 36k | $0 | -1% | Jun 2024 |
|
| Whitebox Advisors | 25k | $502.500000 | 0% | Jun 2024 |
|
| Rivernorth Capital Management | 25k | $499.960000 | 0% | Jun 2024 |
|
| Walleye Trading Advisors | 24k | $1.6k | -8% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 15k | $301.500000 | -25% | Jun 2024 |
|
| Walleye Trading | 14k | $919.472400 | 0% | Mar 2024 |
|
| DuPont Capital Management Corporation | 13k | $250.000000 | 0% | Jun 2024 |
|
| Calamos Advisors | 13k | $250.000000 | 0% | Jun 2024 |
|
| Silver Rock Financial | 12k | $834k | 100% | Mar 2024 |
|
| Exos Asset Management | 3.7k | $74.000000 | 0% | Jun 2024 |
|
| Ancora Advisors | 2.5k | $50.000000 | 0% | Jun 2024 |
|
| Bank of America Corporation | 700.00 | $14.000000 | 250% | Jun 2024 |
|
| Robinson Capital Management | 355.00 | $6.993500 | 100% | Jun 2024 |
|
| Pineridge Advisors | 150.00 | $3.000000 | 0% | Jun 2024 |
|
| Tower Research Capital | 87.00 | $2.001000 | 0% | Jun 2024 |
|
Who sold out of Phoenix Biotech Acquisition?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Radcliffe Capital Management | Dec 2023 | 149k | $4.1k |
| Ionic Capital Management | Mar 2024 | 80k | $5.5k |
| Flow Traders US | Mar 2024 | 18k | $1.0k |
| Susquehanna International | Mar 2024 | 14k | $1.2k |
| Cubist Systematic Strategies | Mar 2024 | 11k | $716.100000 |
| Segantii Capital Management | Dec 2023 | 5.0k | $55k |